2 ARMS/GROUPS: CONTINOUS OUTCOMES (e.g. BMD, BP)

UI Author Year Outcome Unit Exposure/Intervention Mean Follow-up, mo No. Analyzed Baseline Baseline CI/SE/SD * Final or Delta ** Final or Delta CI/SE/SD * Net difference Net difference CI/SE/SD * P between
17661565 Wagner 2006 mom 25 (OH)D at 1 mo ng/mL mom 400 10 32.2 nd
mom 6400 9 34
at 2 mo mom 400 10 35.1
mom 6400 9 47.1
at 3 mo mom 400 10 35.1
mom 6400 9 48.4
at 4 mo mom 400 10 28.9
mom 6400 9 45
at 5 mo mom 400 10 25.9
mom 6400 9 50.6
at 6 mo mom 400 10 33.5
mom 6400 9 51.9
at 7 mo mom 400 10 38.4
mom 6400 9 58.8
17661565 Wagner 2006 mom vit D3 level at 1 mo ng/mL mom 400 10 2.2 nd
mom 6400 9 4.1
at 2 mo mom 400 10 2.8
mom 6400 9 30.3
at 3 mo mom 400 10 3.5
mom 6400 9 32.4
at 4 mo mom 400 10 2.8
mom 6400 9 39.2
at 5 mo mom 400 10 3.7
mom 6400 9 49.6
at 6 mo mom 400 10 5.3
mom 6400 9 43.9
at 7 mo mom 400 10 4
mom 6400 9 49.7
17661565 Wagner 2006 antirachitic activity in milk at 1 mo IU mom 400 10 59.6 nd
mom 6400 9 82.4
at 2 mo mom 400 10 71.2
mom 6400 9 387
at 3 mo mom 400 10 78.6
mom 6400 9 370.5
at 4 mo mom 400 10 45.7
mom 6400 9 374.4
at 5 mo mom 400 10 68.3
mom 6400 9 555.2
at 6 mo mom 400 10 69.9
mom 6400 9 624.5
at 7 mo mom 400 10 76.3
mom 6400 9 873.5 <0.0003
17661565 Wagner 2006 infant 25 (OH)D at 1 mo ng/mL infant 300 10 13 nd
infant placebo 9 14
at 2 mo infant 300 10 33
infant placebo 9 36
at 7 mo infant 300 10 43
infant placebo 9 46
infant weight at 1 mo Kg infant 300 10 4.7 0.4 0.80
infant placebo 9 4.6 0.7
at 4 mo infant 300 10 6.7 0.5 0.91
infant placebo 9 6.6 0.8
at 7 mo infant 300 10 7.6 0.8 0.30
infant placebo 9 8.4 1.1
infant length at 1 mo cm infant 300 10 54.6 1.1 0.29
infant placebo 9 55.9 2.9
at 4 mo infant 300 10 62.4 1.7 0.75
infant placebo 9 62.8 1.9
at 7 mo infant 300 10 65.5 1.8 0.06
infant placebo 9 69.3 2.9

Baseline=baseline value; Final=final value; Delta=change value from baseline, which is Final-Baseline value; Net difference=differences in deltas

*

Enter outcome metric reported in the unadjusted or adjusted result section

**

Delta value is preferred than the Final value. Please report the direction for the change by using “+” or “−“ sign: e.g. +2.8 or −2.8

From: Appendix C, Evidence Tables: R-Z

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.